ANDROGENETIC ALOPECIA
Clinical trials for ANDROGENETIC ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hair loss gel enters first human safety tests
Disease control CompletedThis early-stage study tested a new topical gel called AH-001 for male pattern baldness. The main goal was to check its safety and how the body absorbs it. Researchers tested different strengths on healthy volunteers and men with hair loss to see how well it was tolerated.
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1 • Sponsor: AnHorn Medicines Co. Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New scalp wash aims to speed healing after hair transplants
Disease control CompletedThis study tested if adding an antibiotic called rifampicin to a standard iodine antiseptic wash could improve results for people getting hair transplants. Sixty-five patients were randomly assigned to receive either the new two-part wash or the standard wash alone before their p…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: NA • Sponsor: Elif Asena KANTARCI • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug tested to fight common hair loss
Disease control CompletedThis study tested an experimental topical treatment called PP405 for common pattern hair loss (androgenetic alopecia). It involved 78 adults to check the treatment's safety, how much of the drug gets into the body, and its early effects. The trial had two parts: a 28-day blinded …
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE2 • Sponsor: Pelage Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Can a special shampoo help thinning hair? study investigates
Symptom relief CompletedThis study tested whether a cosmetic shampoo could help reduce visible hair loss in adults with two common types of hair thinning: telogen effluvium and mild androgenic alopecia. Forty participants used the shampoo for three months while researchers measured changes in hair lengt…
Matched conditions: ANDROGENETIC ALOPECIA
Sponsor: Lacer S.A. • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC